Too many middlemen disconnects you from patients.

See How Close
Lost in Transition Telephones
Lost in Transition

Treating rare disease shouldn’t be like a bad game of telephone, with each step generating chaos and confusion. Patient adherence suffers, quality of care diminishes, manufacturers miss out on vital feedback and cost goes up. But imagine if you could cut past all that. We did.

Learn More

News Details

June 08, 2017

Dohmen celebrates with NORD Rare Impact Award Winners

The Dohmen team recently joined more than 400 people at the National Organization for Rare Disorders (NORD) 2017 Impact Awards ceremony in Washington, D.C. The inspiring evening celebrated individuals and organizations who are making extraordinary contributions to the rare disease community.


DLSS was proud to sponsor the event, demonstrating our continued commitment to the rare disease community, our clients and their patients. As our clients know, our unique wrap-around patient-service model focuses on reducing the burden of disease and increasing therapy adherence through coordinated care, patient education, and comprehensive support.

Read more about the event and award recipients here.

Pictured Above: Danny Williams, Chief Sales & Marketing Officer; Sarah Zwicky, SVP, Corporate Marketing, Public Relations & Communication; Marie E. Lamont, President, Patient Services; Carey Stephenson, Senior Director, Sales Operations; Penny Bemus, SVP, Business Development; Linda Newberry-Ferguson, SVP, Clinical Navigation and Brian Davis, VP, Contracting & Payer Access